<?xml version="1.0"?>
<Articles JournalTitle="International Journal of Hematology-Oncology and Stem Cell Research">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>International Journal of Hematology-Oncology and Stem Cell Research</JournalTitle>
      <Issn>2008-2207</Issn>
      <Volume>8</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Evaluation of Alloimmunization Rate and Necessity of Blood Type and Screening Test among Patients Candidate for Elective Surgery</title>
    <FirstPage>1</FirstPage>
    <LastPage>4</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Ahmad</FirstName>
        <LastName>Gharehbaghian</LastName>
        <affiliation locale="en_US">Hematology and Blood Banking Department, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences; Tehran, Iran. AND Pediatric congenital Hematologic Disorders Research Center, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Behrooz</FirstName>
        <LastName>Ghezelbash</LastName>
        <affiliation locale="en_US">Iranian blood Transfusion Organization Research Center, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sima</FirstName>
        <LastName>Aghazade</LastName>
        <affiliation locale="en_US">Ardebile University of Medical Sciences, Ardebile, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Taher</FirstName>
        <LastName>Hojjati</LastName>
        <affiliation locale="en_US">Mazandaran University of Medical Sciences, Mazandaran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Introduction: Alloimmunization is a reaction of the immune system to foreign antigens. For prevention of alloantibody formation, performing of type and screen test is necessary on a patient's blood specimen as part of pre-transfusion testing.
Materials and method: In this cross-sectional study, type and screen test done for 1420 patients with elective surgery for detection of alloantibody in Imam Khomeini hospital in Ardabil.
Results: Prevalence of alloantibody in this population was 0.92% (13 patients) and 99.2% (1407 patients) showed no alloantibody in their serum. The most prevalent alloantibody was anti-K, anti-E and anti-c. No significant relationship observed between sex and alloimmunization rate.
Conclusion: Performance of type and screen test play an important role in reducing the rate of alloimmunization, and also, could reduce the demands for blood reservation in hospital blood banks.</abstract>
    <web_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/435</web_url>
    <pdf_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/435/362</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>International Journal of Hematology-Oncology and Stem Cell Research</JournalTitle>
      <Issn>2008-2207</Issn>
      <Volume>8</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Assessing the Percent of Necrosis after Neoadjuvant Chemotherapy with 24hr Infusional Cisplatin/3 Days Doxorubicin Intermittent with IfosfamideDoxorubicin for Osteosarcoma</title>
    <FirstPage>5</FirstPage>
    <LastPage>8</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mozhgan Aalam</FirstName>
        <LastName>Samimi</LastName>
        <affiliation locale="en_US">Assistant Professor, Minimally Invasive Surgery Research Center, Iran University Of Medical Science, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Nooshin</FirstName>
        <LastName>Mirkheshti</LastName>
        <affiliation locale="en_US">Medical Doctor, East Sage Research Corporation, Isfahan Science and Technology Town, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Abdolreza</FirstName>
        <LastName>Pazouki</LastName>
        <affiliation locale="en_US">Assistant Professor, Minimally Invasive Surgery Research Center, Iran University Of Medical Science, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Introduction: Osteosarcoma is the most common primary bone tumor in children and young adults and appropriate chemotherapy can increase limb sparing and overall survival. Yet, the toxicity of chemotherapy regimens including MTX can be life threatening. Therefore; we tried another chemotherapy regimen for these patients.
Method and materials: We investigated 15 patients aged 15 to 40 years old and used continuous infusion of cisplatin, doxorubicin intermittently with ifosfamide, doxorubicin as neoadjuvant chemotherapy. Percent of necrosis and toxicities was recorded for each patient.
Results: Out of 15 patients investigated, 13 were males and 2 females. Tumor necrosis&#x2265; 90% (defined as good necrosis) was observed in 60% of patients. 26.7% of the patients showed leucopenia grade three or four, 26.7% had anemia grade three or four, and 20% showed thrombocytopenia grade three or four.
Conclusion: The above chemotherapy regimen can cause as good necrosis as the chemotherapy regimens including high dose of MTX with reduced toxicity and less nursing cares and laboratory tests. Of course small sample size limits extension of our result to all patients but trying this regimen is recommended in more patients to see more reliable results.</abstract>
    <web_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/434</web_url>
    <pdf_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/434/363</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>International Journal of Hematology-Oncology and Stem Cell Research</JournalTitle>
      <Issn>2008-2207</Issn>
      <Volume>8</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Role of Epigenetics in the Induction of Fetal Hemoglobin: A Combination Therapy Approach</title>
    <FirstPage>9</FirstPage>
    <LastPage>14</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Ahmadvand</LastName>
        <affiliation locale="en_US">Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mehrdad</FirstName>
        <LastName>Noruzinia</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, School of Medicine, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali Dehghani</FirstName>
        <LastName>Fard</LastName>
        <affiliation locale="en_US">Sarem Cell Research Center- SCRC, Sarem Women's Hospital, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mostafa Montazer</FirstName>
        <LastName>Zohour</LastName>
        <affiliation locale="en_US">Genetics of noncommunicable disease research center, Zahedan University of Medical Science, Zahedan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Amin</FirstName>
        <LastName>Tabatabaiefar</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Soleimani</LastName>
        <affiliation locale="en_US">Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Saeid</FirstName>
        <LastName>Kaviani</LastName>
        <affiliation locale="en_US">Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Saeid</FirstName>
        <LastName>Abroun</LastName>
        <affiliation locale="en_US">Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sahar</FirstName>
        <LastName>Beiranvand</LastName>
        <affiliation locale="en_US">Sarem Cell Research Center- SCRC, Sarem Women's Hospital, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Najmaldin</FirstName>
        <LastName>Saki</LastName>
        <affiliation locale="en_US">Health research center, Research Center of Thalassemia &amp; Hemoglobinopathy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: &#x3B2;-thalassemia considers worldwide public health disorders. Novel fetal hemoglobin inducer agents such as thalidomide and sodium butyrate have been attended for ameliorating clinical complications of such disorders.
Material and Methods: We used thalidomide and sodium butyrate for increasing the level of fetal hemoglobin in erythroid progenitors. Briefly, after isolation of CD133+ stem cells from umbilical cord blood and differentiation into erythroid lineage, erythroid progenitors were treated with thalidomide and sodium butyraye as single and combination. H3K4 histone methylation was evaluated following fetal hemoglobin induction using chromatin immuno percipitation (ChIP) technique.
Results: The results of this study showed that the effect of thalidomide on increasing of H3K4 methylation was highest compared to sodium butyrate and combination of both agents (p &lt; 0.05).
Conclusion: Consequently, our study of the epigenetic modification of the &#x3B3;-globin suggests that histone H3K4 dimethylation are significant for the regulation of developmental stage-specific expression of the &#x3B3;-globin genes.</abstract>
    <web_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/433</web_url>
    <pdf_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/433/364</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>International Journal of Hematology-Oncology and Stem Cell Research</JournalTitle>
      <Issn>2008-2207</Issn>
      <Volume>8</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Effect of miR-210 Up-regulation on Proliferation and Survival of Mouse Bone Marrow Derived Mesenchymal Stem Cell</title>
    <FirstPage>15</FirstPage>
    <LastPage>23</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Neda</FirstName>
        <LastName>Minayi</LastName>
        <affiliation locale="en_US">Hematology Department, Allied Medical School, Tehran University of Medical sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shaban</FirstName>
        <LastName>Alizadeh</LastName>
        <affiliation locale="en_US">Hematology Department, Allied Medical School, Tehran University of Medical sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Dargahi</LastName>
        <affiliation locale="en_US">Health care services Department, Medical School, Tehran University of Medical sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Soleimani</LastName>
        <affiliation locale="en_US">Hematology Department, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra Kashani</FirstName>
        <LastName>Khatib</LastName>
        <affiliation locale="en_US">Hematology Department, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Behnoosh</FirstName>
        <LastName>Tayebi</LastName>
        <affiliation locale="en_US">Hematology Department, Qaem Hospital, Mashad University of Medical sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mozhde</FirstName>
        <LastName>Mohammadian</LastName>
        <affiliation locale="en_US">Hematology Department, Tabriz University of Medical sciences, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sadegh</FirstName>
        <LastName>Alijani</LastName>
        <affiliation locale="en_US">Hematology Department, Allied Medical School, Tehran University of Medical sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Farshid</FirstName>
        <LastName>Karami</LastName>
        <affiliation locale="en_US">Hematology Department, Allied Medical School, Tehran University of Medical sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Bone marrow derived mesenchymal stem cells (MSCs) are a population of multipotent progenitors which have the capacity of proliferation and differentiation into mesenchymal lineage cells. Hypoxia could promote the proliferation of MSCs. Micro-RNAs are endogenous RNAs that can play an important role in some processes such as proliferation and differentiation. MiR-210 could help for better proliferation of MSCs since this miRNA could activate HIF pathway. In current study we investigated if MSCs can preserve their differentiation and proliferation ability under normoxic conditions by upregulation of miR-210.
Materials and Methods: MSCs isolated from C57 BL/6 mice by flushing it's femurs into the cell culture media. After 72 hours, MSCs which are plastic adherent cells were attached to the flask and non-adherent cells were removed. Subsequently, MSCs induced to differentiate into osteocytes and adipocytes with specific differentiation media in order to confirm their identity and multipotency. Then miR-210 was inserted in Lentiviruse vectors and affected MSCs. In each passage, the number and viability of cells were evaluated.
Results: Comparison between miR-210 infected MSCs with control cells showed that miR-210 has ability to increase proliferation of MSCs significantly.
Conclusion: We showed that miR-210 has ability to induce proliferation of MSCs without any negative effect on their differentiation abilities. Further studies are needed for evaluation of probable effects of miR-210 mechanisms on MSCs proliferation.</abstract>
    <web_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/432</web_url>
    <pdf_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/432/365</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>International Journal of Hematology-Oncology and Stem Cell Research</JournalTitle>
      <Issn>2008-2207</Issn>
      <Volume>8</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">High School Knowledge and Attitudes towards Thalassemia in Southeastern Iran</title>
    <FirstPage>24</FirstPage>
    <LastPage>30</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Ebrahim</FirstName>
        <LastName>Miri-Moghaddam</LastName>
        <affiliation locale="en_US">Genetics of Non-Communicable Disease Research Centre, Zahedan University of Medical Sciences, Zahedan, Iran. AND Department of Genetics, Zahedan University of Medical Sciences, Zahedan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Eisa</FirstName>
        <LastName>Motaharitabar</LastName>
        <affiliation locale="en_US">Students Scientific Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Leila</FirstName>
        <LastName>Erfannia</LastName>
        <affiliation locale="en_US">Department of Health Information Technology, Zahedan University Of Medical Sciences, Zahedan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Dashipour</LastName>
        <affiliation locale="en_US">Department of Nutrition and Food Sciences, Zahedan University of Medical Sciences, Zahedan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Marziyeh</FirstName>
        <LastName>Houshvar</LastName>
        <affiliation locale="en_US">Students Scientific Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objectives: Thalassemia (thal) is the most single gene disorders in southeast of Iran. About one quarter of&#xA0;total Iranian new thal cases were born in the Sistan and Balouchistan province so the aim of this study is to&#xA0;assess knowledge level and attitudes towards thal in high school students in Zahedan, capital of Sistan and&#xA0;Balouchistan province in Iran.
Study design: cross- sectional descriptive survey&#xA0;
Methods: this study was conducted on 762 Zahedan high school boys and girls students in 2009. The&#xA0;structured questionnaires were completed by students which consisted of three parts, namely&#xA0; emographic&#xA0;characteristics, knowledge part by 20 multiple choice questions and attitude part by 9 questions.&#xA0;
Results: The results indicated that only 14.7 % students had good knowledge, good knowledge towards thal&#xA0;was 16.2% in boys and 29.1% in girls (P-value&lt;0.001), positive attitude was 76.7% in boys and 84.7% in&#xA0;girls (P-value&lt;0.029). Negative attitude in students who were born in villages and cities were 33.3% and&#xA0;20.7% respectively (P-value=0.04). Good knowledge level in experimental field studied was between 2-4-fold&#xA0;more than other field students. Students in the last year high school had more knowledge and more positive&#xA0;attitude. Students&#x2019; knowledge score had no significant relationship with father education level (P-value=0.11)&#xA0;but had considerable difference with mother educational level (P-value=0.03).
Conclusions: It is concluded that long term and target based programs are suggested for high school&#xA0;students and local population of Sistan and Balouchistan where the trend of family marriages is quite high.&#xA0;These programs would impart valuable education and improve knowledge of people towards thal being&#xA0;couples in pre-marriage period and then after becoming parents thereby reducing the effects of disease.</abstract>
    <web_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/431</web_url>
    <pdf_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/431/366</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>International Journal of Hematology-Oncology and Stem Cell Research</JournalTitle>
      <Issn>2008-2207</Issn>
      <Volume>8</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Adiponectin and Leptin Molecular Actions and Clinical Significance in Breast Cancer</title>
    <FirstPage>31</FirstPage>
    <LastPage>40</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mohan Reddy</FirstName>
        <LastName>Nalabolu</LastName>
        <affiliation locale="en_US">Research Scholar, Bhagwan Mahavir Medical Research Center, Department of Genetics, Mahavir Marg, A.C.Guards, Hyderabad-500004, Andhra Pradesh, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Kalyani</FirstName>
        <LastName>Palasamudram</LastName>
        <affiliation locale="en_US">Research Scholar, Bhagwan Mahavir Medical Research Center, Department of Genetics, Mahavir Marg, A.C.Guards, Hyderabad-500004, Andhra Pradesh, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Kaiser</FirstName>
        <LastName>Jamil</LastName>
        <affiliation locale="en_US">Research Scholar, Bhagwan Mahavir Medical Research Center, Department of Genetics, Mahavir Marg, A.C.Guards, Hyderabad-500004, Andhra Pradesh, India.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Obesity is an important public health problem and major risk factor for postmenopausal breast cancer. Adipose tissue is the major component involved in the control of the metabolism through energy homeostasis, adipocyte differentiation, insulin sensitivity and the activation of anti-inflammatory metabolic and immune pathways. Leptin and Adiponectin pathways are involved in proliferation process in breast cancer. Current review describes potential relationship between the molecular actions and clinical significance of leptin and adiponectin in breast cancer.</abstract>
    <web_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/430</web_url>
    <pdf_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/430/367</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>International Journal of Hematology-Oncology and Stem Cell Research</JournalTitle>
      <Issn>2008-2207</Issn>
      <Volume>8</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A 34 Year Old Man with Purple Discoloration and Paresthesia</title>
    <FirstPage>41</FirstPage>
    <LastPage>5</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Aida</FirstName>
        <LastName>Iranpour</LastName>
        <affiliation locale="en_US">Department of Oncology and Rheumatology, Rasool Akram Hospital, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Reihaneh</FirstName>
        <LastName>Mahmoodian</LastName>
        <affiliation locale="en_US">Department of Oncology and Rheumatology, Rasool Akram Hospital, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Anoosheh</FirstName>
        <LastName>Haghighi</LastName>
        <affiliation locale="en_US">Department of Oncology and Rheumatology, Rasool Akram Hospital, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Vakili</LastName>
        <affiliation locale="en_US">Department of Oncology and Rheumatology, Rasool Akram Hospital, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Shahriari-Ahmadi</LastName>
        <affiliation locale="en_US">Department of Oncology and Rheumatology, Rasool Akram Hospital, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shokoufeh</FirstName>
        <LastName>Hajsadeghi</LastName>
        <affiliation locale="en_US">Department of Oncology and Rheumatology, Rasool Akram Hospital, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohsen</FirstName>
        <LastName>Arabi</LastName>
        <affiliation locale="en_US">Department of Oncology and Rheumatology, Rasool Akram Hospital, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Secondary systemic vasculitis and nonbacterial endocarditis are rare events. We report a case presented with different manifestations of underlying malignancy such as systemic vasculitis, non bacterial endocarditis and DIC (disseminated intravascular coagulopathy). Efforts to find the source of malignancy was unsuccessful and due to patient's unwillingness for further evaluation, finally under the diagnosis of metastatic disease of unknown primary, patient is receiving cyclic chemotherapy.</abstract>
    <web_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/429</web_url>
    <pdf_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/429/368</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>International Journal of Hematology-Oncology and Stem Cell Research</JournalTitle>
      <Issn>2008-2207</Issn>
      <Volume>8</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A Case of Colon Cancer with Breast Metastasis and Krukenberg Tumor</title>
    <FirstPage>46</FirstPage>
    <LastPage>50</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mohsen</FirstName>
        <LastName>Vakili Sadeghi</LastName>
        <affiliation locale="en_US">Medical oncologist, assistant professor of Babol University of medical sciences, Babol, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Majid</FirstName>
        <LastName>Sharbatdaran</LastName>
        <affiliation locale="en_US">Pathologist, assistant professor of Babol University of medical sciences, Babol, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Askari</FirstName>
        <LastName>Noorbaran</LastName>
        <affiliation locale="en_US">General Surgeon, assistant professor of Babol University of medical sciences, Babol, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sepideh</FirstName>
        <LastName>Siadati</LastName>
        <affiliation locale="en_US">Pathologist, assistant professor of Babol University of medical sciences, Babol, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Daryoush</FirstName>
        <LastName>Moslemi</LastName>
        <affiliation locale="en_US">Radiation oncologist, assistant professor of Babol University of medical sciences, Babol, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shahriar</FirstName>
        <LastName>Shafahi</LastName>
        <affiliation locale="en_US">Pathologist, assistant professor of Babol University of medical sciences, Babol, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Colorectal cancer most commonly metastasizes to the liver and lung. Metastatic colon carcinoma (MCC) to the breast is extremely rare. Krukenberg tumor is an uncommon metastatic tumor of the ovary.
Case presentation: A 38 years woman presented with abdominal pain. In evaluation colon cancer was diagnosed at stage 3. FOLFOX chemotherapy was done. After one year she developed Krukenberg tumor. Few days after ovarian tumor resection breast tumor was diagnosed. In immunohistochemistry both ovarian and breast tumors was CK7 negative, CK20 positive, compatible with colon cancer origin. This is the first case of simultaneous metastasis of colon cancer to two rare sites.</abstract>
    <web_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/428</web_url>
    <pdf_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/428/369</pdf_url>
  </Article>
</Articles>
